Early Remdesivir to prevent progression to severe Covid-19 in outpatients - Community99

Retrieved on: 2022-03-14 02:10:24

Tags for this article:

Click the tags to see associated articles and topics

Early Remdesivir to prevent progression to severe Covid-19 in outpatients - Community99. View article details on hiswai:

Excerpt

Patients were randomly assigned to a 1: 1 ratio to receive intravenous remdesivir (200 mg on day 1 followed by 100 mg on days 2 and 3) or placebo.

Article found on: community99.com